Details for 2015700726
Up to date per 02.04.2026
Actions
Details for 2015700726
Granted/Registered
European Patent
30.11.2016 A
10.07.2019 B1
21.01.2014
US
201461929795 P
04.02.2014
EP
14153887
04.02.2014
EP
14153880
03.09.2014
EP
14183324
02.10.2014
EP
14187429
15.12.2014
US
201462091668 P
A61K 45/06 20060101AFI20190131BHEP
Owner
Janssen Pharmaceutica, N.V.Turnhoutseweg 30 2340 BeerseBE
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
KLEIN, Brian, Dc/o: Neuroadjuvants Inc. 417 Wakara Way Suite 3510 Salt Lake City, UT 84108US
LAVREYSEN, Hildec/o: Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE
PYPE, Stefan, Maria, Christiaanc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE
TWYMAN, Roy, Ec/o: Janssen R&D US 1125 Trenton-Harbourton Road PO BOX 300 Titusville, New Jersey NJ 08560US
VAN OSSELAER, Nancy, Eulalie, Sylvainc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE
WHITE, H., Stevenc/o: Neuroadjuvants Inc. 417 Wakara Way, Suite 3510 Salt Lake City, UT 84108US
CEUSTERS, Marc, Andréc/o: Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE
CID-NÚÑEZ, José, Mariac/o: Janssen-Cilag S.A. Calle Jarama 75 Poligono Industrial E-45007 ToledoES
TRABANCO-SUÁREZ, Andrés, Avelinoc/o: Janssen-Cilag S.A. Calle Jarama 75 Poligono Industrial E-45007 ToledoES
BONE, Roger, Francisc/o: London Innovation Centre 1 Chapel Place London W1G DBGGB
Information about Fees